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Reversible protein phosphorylation, regulated by protein kinases and phosphatases,
mediates a switch between protein activity and cellular pathways that contribute to a
large number of cellular processes. The Mycobacterium tuberculosis genome encodes
11 Serine/Threonine kinases (STPKs) which show close homology to eukaryotic kinases.
This study aimed to elucidate the phosphoproteomic landscape of a clinical isolate
of M. tuberculosis. We performed a high throughput mass spectrometric analysis of
proteins extracted from an early-logarithmic phase culture. Whole cell lysate proteins were
processed using the filter-aided sample preparation method, followed by phosphopeptide
enrichment of tryptic peptides by strong cation exchange (SCX) and Titanium dioxide (TiO2)
chromatography. The MaxQuant quantitative proteomics software package was used for
protein identification. Our analysis identified 414 serine/threonine/tyrosine phosphorylated
sites, with a distribution of S/T/Y sites; 38% on serine, 59% on threonine and 3%
on tyrosine; present on 303 unique peptides mapping to 214 M. tuberculosis proteins.
Only 45 of the S/T/Y phosphorylated proteins identified in our study had been previously
described in the laboratory strain H37Rv, confirming previous reports. The remaining 169
phosphorylated proteins were newly identified in this clinical M. tuberculosis Beijing
strain. We identified 5 novel tyrosine phosphorylated proteins. These findings not
only expand upon our current understanding of the protein phosphorylation network
in clinical M. tuberculosis but the data set also further extends and complements
previous knowledge regarding phosphorylated peptides and phosphorylation sites in
M. tuberculosis.
Keywords: M. tuberculosis, phosphoproteomics, tyrosine phosphorylation, serine phosphorylation, threonine
phosphorylation
INTRODUCTION
According to the World Health Organization (WHO), tubercu-
losis (TB) ranks as the second leading cause of death from an
infectious disease worldwide, after HIV (WHO|Global tubercu-
losis report 2014, 2014). It is estimated that one third of the
world’s population is infected with Mycobacterium tuberculosis,
the causative agent of TB and 8.6 million new TB cases were
reported in 2012 alone (WHO|Global tuberculosis report 2013,
2013). In order to control this epidemic there is a critical need for
the development of effective and affordable anti-TB therapy and
diagnostic tools.
Harnessing the power of the field of proteomics provides
a unique opportunity to identify novel protein candidates for
diagnosis and drug targets of pathogenic bacteria. Of particular
interest is the identification of proteins with post-translational
modifications (PTMs) as these modifications are often critical
to protein functions, such as regulating protein-protein interac-
tions, subcellular localization or modification of catalytic sites
(Seo and Lee, 2004; Gupta et al., 2007). Protein phosphoryla-
tion is an important reversible PTM that directly or indirectly
regulates signal transduction cascades linking the intracellular
and extracellular environments. In bacteria, protein phosphory-
lation plays a fundamental role in the regulation of key processes
ranging frommetabolism and cellular homeostasis to cellular sig-
naling which can be mediated by two classes of phosphorylation
events (Cozzone, 1998). The underlying molecular mechanisms
regulating protein phosphorylation and dephosphorylation is of
great physiological importance due to its ability to ultimately
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affect protein activity, function, half-life or subcellular localiza-
tion (McConnell and Wadzinski, 2009). Until recently it was
thought that histidine/aspartate phosphorylation was the main
mediator of signal transduction in bacteria (Frasch and Dworkin,
1996). However, with the advancement of mass spectrometry-
based analyses serine/threonine and tyrosine kinases have been
identified in a number of different bacteria (Macek et al., 2007;
Macek and Mijakovic, 2011; Mijakovic and Macek, 2012).
The M. tuberculosis genome encodes 11 Serine/Threonine
kinases (STPK’s) (PknA, PknB, PknD, PknE, PknF, PknG, PknH,
PknI, PknJ, PknK, PknL), two tyrosine phosphatases (PtpA,
PtpB) and 11 two-component systems, highlighting the complex-
ity of signaling network mediated by protein phosphorylation
and thereby their potential as drug targets (Chopra et al., 2003;
Koul et al., 2004; Sharma et al., 2004; Sala and Hartkoorn, 2011).
Prisic et al. described the Serine/Threonine (S/T) phosphoryla-
tion profiles of the laboratory strain M. tuberculosis H37Rv under
6 different culture conditions (Prisic et al., 2010). This study iden-
tified 301 phosphorylated proteins after combining data from six
different culture conditions (Prisic et al., 2010) and identified
four phosphorylated STPKs, ribosomal and ribosome-associated
proteins as well as phosphorylated substrates which suggest that
protein phosphorylation provides a mechanism for regulating
key physiological process during infection. A more recent study
of H37Rv further expanded the knowledge of the phosphopro-
teome by identifying novel tyrosine (Y) phosphorylated proteins
in M. tuberculosis further supporting the broad regulation of its
physiology by phosphorylation (Kusebauch et al., 2014).
In this study we report the phosphoproteome of a previously
described clinical Beijing genotypeM. tuberculosis isolate at early-
logarithmic growth phase in liquid culture to provide further
insight the influence of S/T/Y phosphorylation events on bacterial
growth and virulence (de Souza et al., 2010). We used a combi-
nation of strong cation exchange (SCX) with Titanium dioxide
(TiO2) enrichment in a mass spectrometry-based phosphopro-
teomic analysis of a hyper-virulent clinical M. tuberculosis isolate
(de Souza et al., 2010). We confirmed the presence of previ-
ously described M. tuberculosis phosphorylated proteins and also
identified novel phosphorylated proteins and sites. In addition,
this dataset identified novel tyrosine phosphorylation events, and
thereby confirmed that there are multiple tyrosine kinase targets
in this clinically relevant M. tuberculosis strain.
MATERIALS AND METHODS
CELL CULTURE AND LYSATE PREPARATION
A previously described hyper-virulent clinical Beijing genotype
Mycobacterium tuberculosis isolate, SAW5527, isolated from a TB
patient attending a primary health care clinic in the Western
Cape province, South Africa was used for this phosphopro-
teomics analysis (de Souza et al., 2010). Secondary cultures were
inoculated into 50ml 7H9 Middlebrooks medium supplemented
with Dextrose and Catalase and incubated at 37◦C until early-
logarithmic phase (OD600 between 0.6 and 0.7). Mycobacterial
cells were collected by centrifugation (2000× g for 10min at 4◦C)
and washed two times with cold lysis buffer containing 10mM
Tris-HCl (pH 7.4), 0.1% Tween-80, Complete Protease inhibitor
cocktail (Roche, Mannheim Germany) and Phosphatase inhibitor
cocktail (Roche, Mannheim Germany). An equal amount of
0.1mm glass beads (Biospec Products Inc., Bartlesville, OK) was
added to the cell pellet after centrifugation together with cold
300µl lysis buffer and 10µl DNaseI (2U/ml) (NEB, New England
Laboratories). Lysis was achieved by mechanical bead-beating in
a Rybolyser (Bio101 SAVANT, Vista, CA) for 6 cycles of 20 s at
a speed of 4.0 m.s−1, with 1min cooling periods on ice. The
whole cell lysates were filter-sterilized with a sterile 0.22µm
pore acrodisc 25mm PF syringe filter (Pall Life Sciences, Pall
Corporation, Ann Arbour, MI) and stored at −80◦C. The pro-
tein concentration of the whole cell lysate was determined using
the RCDC Protein assay according tomanufacturer’s instructions
(BioRad). A single biological replicate was analyzed in triplicate
for downstream phosphoproteomic analysis.
FILTER AIDED SAMPLE PREPARATION AND TRYPSIN DIGESTION
Four milligrams of concentrated whole cell lysate proteins was
heated in 4% SDS buffer and 0.1M dithiothreitol (DTT) in
100mMTris/HCl pH 7.5. The samples were processed using Filter
Aided Sample Preparation (FASP) (Wis´niewski et al., 2009). In
brief, 4mg dried whole cell lysate protein was resuspended in
250µl of urea (UA) and loaded onto a 15ml Amicon filtration
device (30 kDa MWCO) and centrifuged at 2000 × g for 40min
at 25◦C. After centrifugation, the flow-through was collected in
a clean falcon tube and discarded. The concentrated whole cell
lysate proteins in the filter unit were diluted in 2ml 8M Urea in
0.1M Tris/HCl (pH 8.5) and re-centrifuged to remove the SDS.
The flow-through was discarded and the remaining proteins in
the filter unit were alkylated by mixing with 1.5ml 50mM iodac-
etamide (IAA) and incubated in the dark for 20min to irreversibly
modify cysteine. The alkylated proteins were equilibrated with
2ml 50mM ammonium bicarbonate (ABC) and digested with
trypsin (Promega) in a protein to enzyme ratio of 100:1 at 37◦C
overnight. After trypsin digestion the filter unit is transferred to a
clean collection tube and the peptides were eluted by centrifuged
at 14 000× g for 10min. The eluted peptides were diluted in 50µl
water to avoid desalting for further processing of the peptide and
acidified with trifluoroacetic acid (TFA).
FRACTIONATION OF PEPTIDES BY STRONG CATION EXCHANGE (SCX)
Extracted trypsin digested peptides were diluted to a volume of
7ml in Solvent A (5mM monopotassium phosphate (KH2PO4)
30% acetonitrile (ACN), pH 2.7). The pH of the diluted pep-
tide samples was adjusted to 2.7 and made up to a volume of
10ml with 100% ACN. The respective peptide samples were
then separated at pH 2.7 by strong cation exchange (SCX ) by
loading each peptide mixture onto a cation exchanger column
(3.0mm × 20 cm) (Poly LC, Columbia, MD) containing 5µm
polysulfoethyl aspartamine beads with a 200 Å pore size and
a flow rate of 350µl/min−1 equilibrated with SCX solvent A.
The flow-through was collected and the bound peptides were
eluted from the columns using an increasing salt gradient (0–
30%) containing 5mM KH2PO4 pH and 150mM KCl. A total
of 9 fractions were collected; 5 fractions generated by SCX based
on UV absorbance (220 and 280), 3 from the flow-through and
1 salvage fraction (containing washes from the cation exchanger
column) from the SCX column as an additional fraction.
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ENRICHMENT OF PHOSPHOPEPTIDES WITH TiO2 BEADS
All nine fractions (5 SCX, 3 SCX flow-through, 1 salvage frac-
tion) were subjected to Titanium dioxide (TiO2) phosphopeptide
enrichment. The TiO2-beads,10µm in size, (GL Sciences, Inc.,
Japan) was resuspended 30mg/ml dihydrobenzoic acid (DHB)
(Sigma) to prevent non-specific binding. Each of the 9 fractions
was incubated 4 times with TiO2 at a peptide to bead ratio of
1:2–1:8. Each fraction was rotated for 30min, and then briefly
centrifuged (14,000 g × 30 s). The supernatants were aspirated
and transferred to a new labeled tube and the phosphopeptides
bound to the TiO2beads were washed twice with 30% ACN and
3% TFA followed by washing twice with 75% ACN and 0.3%
TFA. The enriched phosphorylated peptides were eluted with elu-
tion buffer containing 25% ammonia and ACN pH10. The eluted
phosphopeptides were desalted using in house prepared C18
Stage tips.
LC-MS/MS ANALYSIS
The peptides were separated on a column packed in-house with
C18 beads (reprosil-AQ Pur, RdMaisch) on an Proxeon Easy-nLC
system (Proxeon Biosystems, Odense, Denmark) using a binary
gradient with buffer A (0.5% acetic acid in water) and buffer B
(0.5% acetic acid and 80% ACN). The 4µl of the enriched phos-
phopeptides from each of the 9 fractions were injected 3 times and
were loaded directly without any trapping column with buffer A
at a flow rate of 500 nl/min. Elution was carried out at a flow rate
of 250 nl/min, with a linear gradient from 10 to 35% buffer B
over a period of 95min followed by 50% buffer B for 15min. At
the end of the gradient the column was washed with 90% buffer B
and equilibrated with 5% buffer B for 10min. The LC system was
directly coupled in-line with the LTQ-Orbitrap Velos instrument
(Thermo Fisher Scientific) via the Proxeon Biosystems nano-
electrospray source. The mass spectrometer was programmed to
acquire in a data-dependant mode with a resolution of 30,000
at 400m/z with lock mass option enabled for the 445.120025.
However, the target lockmass abundance was set to 0% in order to
save the injection time for lock mass. For full scans 1E6 ions were
accumulated within a maximum injection time of 250ms in the
C trap and detected in the Orbitrap mass analyser. The 10 most
intense ions with charge states ≥2 were sequentially isolated and
fragmented by high-energy collision dissociation (HCD) mode
in the collision cell with normalized collision energy of 40% and
detected in the Orbitrap analyser at 75,000 resolution. For HCD
based method, the activation time option in the Xcalibur file was
set to 0.1ms. For the high-low strategy, full scans were acquired
in the Orbitrap analyser at 60,000 resolution as parallel acquisi-
tion is enabled in the high-low mode. Up to the 10 most intense
peaks with charge states ≥2 were selected for sequencing to a tar-
get value of 5000 with a maximum injection time of 25ms and
fragmented in the ion trap by HCD with normalized collision
energy of 35%, activation of 0.25 and activation time of 10ms.
DATABASE SEARCH
The raw data acquired were processed using MaxQuant software
version (1.4.1.2) and processed as per default workflow. Since
HCD spectra were acquired in profile mode, deisotoping was
performed similar to survey MS scans to obtain singly charged
FIGURE 1 | Growth curves of hyper-virulent M. tuberculosis Beijing
strain. Growth monitored over a 24 day period using OD600 measurements
in 7H9 Middlebrooks liquid media supplemented with dextrose and
catalase.
peak lists and searched against the M. tuberculosis H37Rv protein
database (version R11 tuberculist.epfl.ch). The search included
cysteine carbamidomethylation as a fixed modification while
N-acetylation, oxidation of methionine and phosphorylation at
serine, threonine and tyrosine were set as variable modifications.
Up to two missed cleavages were allowed for protease digestion
and a peptide had to be fully tryptic. Identifications were fil-
tered at 1% FDR at three levels namely; site, peptide and protein
using reversed sequences. As such there is no fixed cut-off score
threshold but instead spectra were accepted until the 1% false
discovery rate (FDR) is reached. Only peptides with a minimum
length of 7 amino acids were considered for identification and
detected in at least one or more of the replicates. All phospho-
peptide spectra were manually validated by applying stringent
acceptance criteria: only phosphorylation events on S/T/Y with
a localization probability of ≥0.75 and PEP ≤ 0.01 were used
for further analysis and reported as high confidence localized
phosphosites.
GENE ONTOLOGY ANALYSIS
The categorization of identified phosphorylated proteins in
terms of functional categorization, molecular function, biolog-
ical processes and cellular components was carried out using
TubercuList-Mycobacterium tuberculosis Database.
RESULTS
In this study we set out to analyse the phosphoproteome of a
hyper-virulent Beijing genotypeM. tuberculosis isolate by extract-
ing whole cell lysate proteins at early-logarithmic growth (OD600
of 0.8) (Figure 1) which resulted in the identification of 619
MS/MS spectra. The 274 LC-MS/MS spectra that fulfilled the cri-
teria for high confidence phosphosites identified a total of 414
(38:59:3%) S/T/Y phosphorylation sites present in 214 M. tuber-
culosis H37Rv proteins (Supplementary Table S2; Supplementary
Figure S1).
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Table 1 | List of phosphopeptides identified in this and previous studies of M. tuberculosis.
Rv numbers Protein name Phosphopeptides Phospho-residue References
Rv0007 Rv0007 FISGASAPVTGPAAAVR Not known Prisic et al., 2010
FIS*GAS*APVT*GPAAAVR S; T This study
FIS*GASAPVT*GPAAAVR S; T This study
Rv0014c PknB AIADSGNSVTQTAAVIGTAQYLSPEQAR Not known Prisic et al., 2010
AIADSGNSVT*QT*AAVIGTAQYLSPEQAR T This study
AIADSGNS*VT*QTAAVIGTAQYLSPEQAR S; T This study
TSLLSSAAGNLSGPRTDPLPR Not known Prisic et al., 2010
TSLLSSAAGNLS*GPRTDPLPR S This study
TSLLSSAAGNLSGPRT*DPLPR T This study
Rv0015c PknA RPFAGDGALT$VAMK T Prisic et al., 2010; This study
Rv0020c FhaA FEQSSNLHTGQFR Not known Prisic et al., 2010
FEQS*SNLHT*GQFR S; T This study
HPDQGDY$PEQIGYPDQGGYPEQR Y Kusebauch et al., 2014; This study
QDYGGGADY$TR Y Kusebauch et al., 2014; This study
VPGY$APQGGGYAEPAGR Y Kusebauch et al., 2014; This study
Rv0175 Rv0175 AADSAESDAGADQTGPQVK Not known Prisic et al., 2010
AADSAESDAGADQT*GPQVK T This study
Rv0204c Rv0204c DPPT$DPNLR Prisic et al., 2010; This study
Rv0227c Rv0227c GGFEEPVPGAEAETEKLPTQRPDFPR Not known Prisic et al., 2010
GGFEEPVPGAEAET$EK T Prisic et al., 2010; This study
Rv0351 GrpE RIDPET#GEVR T Prisic et al., 2010
IDPET*GEVR T This study
Rv0389 PurT AAGHQVQPQT$GGVSPR T Prisic et al., 2010; This study
Rv0410c PknG SGPGTQPADAQTAT#SATVRPL T O’Hare et al., 2008
S*GPGT*QPADAQTATSATVR S; T This study
SGPGTQPADAQTAT*S*ATVRPLSTQAVFR S; T This study
SGPGTQPADAQTAT*SAT*VR T This study
PLST#QAVFRPDFGDEDNFPHPTLGPDTEPQDR T O’Hare et al., 2008
PLS*T*QAVFR S; T This study
Rv0421c Rv0421c GLAEGPLIAGGHS#YGGR S Prisic et al., 2010
GLAEGPLIAGGHS*Y*GGR S; Y This study
Rv0440 GroEL2 KWGAPTIT$NDGVSIAK T Molle et al., 2006
WGAPTIT*NDGVSIAK T This study
AVEKVT#ETLLK T Molle et al., 2010
VTET*LLK T This study
Rv0497 Rv0497 RGDSDAITVAELT$GEIPIIR T Prisic et al., 2010; This study
T*GPHPETESSGNR T This study
Rv0685 Tuf PDLNET$KAFDQ T Sajid et al., 2011
VLHDKFPDLNET*K T This study
Rv0733 Adk LGIPQISTGELFR Not known Prisic et al., 2010
LGIPQIS*TGELFR S This study
Rv0822c Rv0822c VHDDADDQQDTEAIAIPAHSLEFLSELPDLR Not Known Prisic et al., 2010
VHDDADDQQDT*EAIAIPAHSLEFLSELPDLR T This study
Rv0896 GltA2 ADTDDT$ATLR T Prisic et al., 2010; This study
Rv0931c PknD PGLTQT$GTAVG T Durán et al., 2005; This study
AASDPGLT*QT*GTAVGTYNYMAPER T This study
WSPGDS*AT*VAGPLAADSR S; T This study
WSPGDSATVAGPLAADSR Not known Prisic et al., 2010
WSPGDS*AT*VAGPLAADSR S; T This study
WSPGDS*ATVAGPLAADS*R S This study
Rv1388 MihF AQEIMTELEIAPT$RR T Prisic et al., 2010; This study
Rv1719 Rv1719 S$GGIQVIAR S Prisic et al., 2010This study
(Continued)
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Table 1 | Continued
Rv numbers Protein name Phosphopeptides Phospho-residue References
Rv1746 PknF DDTRVS$QPVAV S Durán et al., 2005; This study
Rv1747 Rv1747 YPTGGQQLWPPSGPQR T Prisic et al., 2010
YPT*GGQQLWPPS*GPQR S; T This study
IPAAPPSGPQPR Not known Prisic et al., 2010
IPAAPPS*GPQPR S This study
Rv1820 IlvG STDTAPAQTMHAGR Not Known Prisic et al., 2010
STDT*APAQTMHAGR T This study
Rv1827 GarA DQTSDEVTVETTSVFR Not known Prisic et al., 2010
DQTSDEVT*VET*T*SVFR T This study
VTVETT$SVFRA T Prisic et al., 2010; This study
DQTSDEVTVET$TSVFR T Villarino et al., 2005; This study
DQT*SDEVTVET*TSVFR T This study
DQTSDEVT*VET*TSVFR T This study
DQTSDEVTVET*T*SVFR T This study
DQTSDEVT*VET*T*SVFR T This study
Rv2094c TatA VDPSAASGQDS*T*EARPA S; T This study
AEASIETPTPVQSQR Not known Prisic et al., 2010
AEAS*IETPTPVQSQR S This study
AEASIETPT*PVQSQR T Prisic et al., 2010; This study
VDPSAASGQDSTEARPA Not known Chou et al., 2012
VDPSAASGQDST*EARPA T This study
Rv2127 AnsP1 ERLGHT$GPFPAVANPPVR T Prisic et al., 2010; This study
Rv2151c FtsQ VADDAADEEAVT#EPLATESK T Prisic et al., 2010; This study
Rv2197c Rv2197c MAEAEPATRPT#GASVR T Prisic et al., 2010; This study
MAEAEPAT#RPTGASVR T Prisic et al., 2010
MAEAEPAT*RPT*GASVR T This study
Rv2198c MmpS3 ASGNHLPPVAGGGDKLPSDQTGETDAYSR Not known Prisic et al., 2010
ASGNHLPPVAGGGDKLPSDQT*GETDAY$SR T; Y Kusebauch et al., 2014; This study
Rv2536 Rv2536 ADDSPTGEMQVAQPEAQTAAVATVER Not known Prisic et al., 2010
AADTDVFSAVR Not known Prisic et al., 2010
AADT*DVFS*AVR T This study
Rv2536 Rv2536 EAPT$EVIR T Prisic et al., 2010; This study
ADDSPT*GEMQVAQPEAQTAAVAT*VER T This study
ADDS*PTGEMQVAQPEAQTAAVATVER S This study
Rv2606c SnzP MDPAGNPATGT$AR T Prisic et al., 2010; This study
MDPAGNPAT*GTAR T This study
Rv2694c Rv2694c RIPGIDT$GR T Prisic et al., 2010; This study
Rv2696c Rv2696c EAAAAQADT#QRQAAAGVAR T Prisic et al., 2010
EAAAAQADT*QR T This study
Rv2921 FtsY IDTSGLPAVGDDATVPR Not known Prisic et al., 2010
IDTS*GLPAVGDDATVPR S This study
IDT*SGLPAVGDDAT*VPR T This study
IDT*SGLPAVGDDAT*VPR T This study
Rv2940c Mas ALAQYLADTLAEEQAAAPAAS$ S Prisic et al., 2010; This study
Rv2996c SerA1 SATTVDAEVLAAAPK Not known Prisic et al., 2010
SAT*TVDAEVLAAAPK T This study
S*ATTVDAEVLAAAPK S This study
Rv3181c Rv3181c LAALDST#DTLER T Prisic et al., 2010
LAALDST*DT*LER T This study
Rv3197 Rv3197 S#KDEVTAELMEK S Prisic et al., 2010
Rv3200c Rv3200c QSGADTVVVSS$ETAGR S Prisic et al., 2010; This study
QSGADTVVVS*SETAGR S This study
(Continued)
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Table 1 | Continued
Rv numbers Protein name Phosphopeptides Phospho-residue References
Rv3248c SahH GVTEETTTGVLR Not known Prisic et al., 2010
GVTEETT*T*GVLR T This study
GVTEET*TTGVLR T This study
Rv3604c Rv3604c TADTPPDDSGGLHAR Not known Prisic et al., 2010
TADTPPDDS*GGLHAR S This study
DPLTGGQSVADLMAR Not known Prisic et al., 2010
DPLT$GGQSVADLMAR T Prisic et al., 2010; This study
Rv3801c FadD32 FDPEDTSEQLVIVGER Not known Prisic et al., 2010
FDPEDT*SEQLVIVGER T This study
Rv3817 Rv3817 LWQAEDDS*S*R S This study
RLWQAEDDSSR Not known Prisic et al., 2010
Rv3868 EccA1 LAQVLDIDT$LDEDRLR T Prisic et al., 2010; This study
*Novel phosphorylated amino acid identified in this study.
#Phosphorylated residue identified in previous studies.
$Phosphorylated residue identified in current and previous studies.
Of the 401 serine/threonine phosphorylation sites (pS/T), only
156 had been previously described for M. tuberculosis (Table 1).
Only 6 of 13 tyrosine phosphorylation sites (pY) has been pre-
viously described for M. tuberculosis (Kusebauch et al., 2014).
The remaining 245 pS/T and 7 pY were uniquely identified
in this study (Supplemental Table S2). To determine whether
phosphorylated proteins were differentially represented in any
particular cellular process, we grouped the phosphorylated pro-
teins based on their functional category according to Tuberculist
(Lew et al., 2011) (Figure 2). One hundred and seventy (79.4%)
of the phosphorylated proteins had an annotated function, while
the remaining 59 phosphorylated proteins (20.5%) were assigned
as hypothetical. The biological function of the annotated pro-
teins varied from transcription, translation, protein biosynthesis,
fatty acid metabolism to phosphorylation. Our analysis identified
phosphorylated forms of the 9 of the 11 M. tuberculosis STPK’s:
PknA, PknB, PknD, PknF, PknG PknE, PknH, PknJ, and PknL
(Table 2). Of these, phosphorylated forms of PknE, PknH, PknJ,
and PknL had not been previously described in M. tuberculosis.
We detected 13 Y phosphorylation sites located on 10 proteins
in M. tuberculosis during early-logarithmic growth. Six of the 13
Y phosphorylation sites (Table 3) were located on two proteins,
FhaA and MmpS3 (Kusebauch et al., 2014) and have recently
been described in a M. tuberculosis H37Rv at stationary growth
phase. The remaining 7 Y phosphorylated sites were uniquely
identified in this study. Amongst these with known annotations
were 2 virulence factors (GroS and GroEL2) and Ppa involved in
macromolecule biosynthesis.
A large number of proteins involved in intermediary
metabolism and respiration processes such as lipid and fatty acid
metabolism (KasB, FadD32, AccD4, and MmaA3) were found to
be phosphorylated in this study (Supplemental Table S2). In addi-
tion, several proteins from the ESX-1 type seven secretion system
(T7SS) in M. tuberculosis including EspR, EccA, CFP10, EspI,
EspL, EspB were amongst the identified phosphorylated proteins
(Supplemental Table S1).We also identified virulence factors such
Pks15, AceA5, FadD5, EsxB, KatG, GlpX, Rv2032, and PtbB that
were phosphorylated in this hyper-virulent M. tuberculosis strain
(Supplemental Table S2).
Of the 21 phosphorylated proteins involved in information
pathways, we identified 6 phosphorylated ribosomal proteins; two
phosphorylated small subunit (30S) ribosomal proteins (S3, S19),
and four large subunit (50S) ribosomal proteins (L3, L24, L29,
L31) with a total of 8 S/T phosphorylation sites. In addition, phos-
phorylated sites on the ribosomal proteins RpsS and RplX were
also identified (Table 4).
DISCUSSION
Here we report 214 phosphorylated proteins extracted dur-
ing early-logarithmic growth phase from a hyper-virulent clin-
ical Beijing genotype Mycobacterium tuberculosis isolate. These
proteins can be categorized into different biological functions
according to Tuberculist (Lew et al., 2011). The impact of
phosphorylation on these Hank’s type Ser/Thr kinases (STPKs),
phosphatases and their substrates, and the functional role of
phosphorylated residues still remains to be elucidated. However,
as in previous studies, the identification of phosphorylated
residues clearly suggests functional importance.
REGULATORY PROTEINS
In recent years, bacterial S/T/Y kinases and phosphatases have
been extensively investigated, with indications that they might
play a crucial role in pathogenicity. These Hank’s type kinases
have the ability to short-circuit the host defense mechanism since
they are mostly involved in key biological processes. We identi-
fied phosphopeptides from 9 of the 11 STPKs encoded by the
M. tuberculosis genome. This included both previously described
S/T phosphorylation sites (Boitel et al., 2003; Young et al., 2003;
Durán et al., 2005; Villarino et al., 2005; Molle et al., 2006; O’Hare
et al., 2008; Prisic et al., 2010; Sajid et al., 2011; Chou et al., 2012;
Kusebauch et al., 2014) and novel sites on these STPKs thereby
highlighting the complexity of the signal transduction mecha-
nism of this pathogen. Phosphorylated peptides were not detected
for PknI and PknK. However MS/MS spectra for these peptides
Frontiers in Microbiology | Microbial Physiology and Metabolism February 2015 | Volume 6 | Article 6 | 6
Fortuin et al. Phosphoproteome of a clinical Mycobacterium tuberculosis isolate
FIGURE 2 | Functional classification of phosphorylated proteins. Percentage phosphorylated proteins per functional category were classified according to
Tuberculist. Number of phosphorylated proteins identified in each functional category depicted above the black bars.
Table 2 | Serine/threonine kinases and their phosphorylation sites identified in this study.
STPK Phosphorylated residue (position in protein) Phosphopeptides References
PknA T8, S10, T224, S299, T301, T302 AAPAAIPS*GT*T*AR This study
VGVT*LS*GR This study
RPFAGDGALT#VAMK Prisic et al., 2010
PknB S169, T171, T173, S305, T309 AIADSGNS*VT*QTAAVIGTAQYLSPEQAR This study
TSLLSSAAGNLS*GPRTDPLPR This study
AIADSGNSVT*QT*AAVIGTAQYLSPEQAR This study
TSLLSSAAGNLSGPRT*DPLPR This study
PknD T169, T171, S332,T334,S343,S350 GGNWPS*QTGHSPAVPNALQASLGHAVPPAGNK This study
WSPGDS*AT*VAGPLAADSR This study
WSPGDS*ATVAGPLAADS*R This study
AASDPGLT*QT*GTAVGTYNYMAPER This study
PknE S304 LPVPSTHPVS*PGTR This study
PknF T289, S290 LGGAGDPDDT*RVS*QPVAVAAPAK This study
PknG S10, T14, T23, S24, T26, S31, T32, T55 PLS*T*QAVFR This study
S*GPGT*QPADAQTATSATVR This study
SGPGTQPADAQTAT*S*ATVRPLSTQAVFR This study
PDFGDEDNFPHPTLGPDT*EPQDR This study
SGPGTQPADAQTAT*SAT*VR This study
PknH T174 LTQLGT*AVGTWK This study
PknJ S498 HLADLAS*IWRR This study
PknL S306, T309 S*RIT*QQGQLGAK This study
*Novel phosphorylation sites identified in this study.
#Phosphorylated residue identified in previous studies.
for these proteins were detected with mass spectrometry thereby
confirming the presence of these proteins (data not shown).
Of the phosphorylated STPKs, PknA, PknB, and PknG have
been shown to be essential for in vitro growth (Sassetti et al.,
2003) and to regulate cell growth and cell division and inter-
fere with host signaling pathways (Fernandez et al., 2006). PknE,
PknH, PknJ, and PknL have been implicated in the adapta-
tion to the extracellular environment or intracellular survival
of M. tuberculosis (Sharma et al., 2006; Lakshminarayan, 2009;
Arora et al., 2010; Parandhaman et al., 2014) which is in agree-
ment with reports that during early growth the bacilli undergo a
period of adaptation to their external environment (Stock et al.,
1989; Soares et al., 2013). PknE is involved in the suppression
of apoptosis during nitrate stress (Kumar and Narayanan, 2012)
and intracellular survival and adaptation to hostile environments
(Parandhaman et al., 2014). In M. tuberculosis, PknH controls
the expression of a variety of cell wall related enzymes and
regulates in vivo growth in mice (Zheng et al., 2007). PknJ
undergoes autophosphorylation and phosphorylates the Thr168,
Thr171, and Thr173 residues of Embr (a transcriptional regula-
tor), MmaA4/Hma (a methyltransferase involved in mycolic acid
biosynthesis) and PepE (a peptidase located adjacent to the pknJ
gene in the M. tuberculosis genome), respectively (Jang et al.,
2010). Lastly, PknL is involved in an adaptive response to nutri-
ent starvation. This kinase regulates transcription which allows
the bacilli to maintain metabolic activity without sourcing energy
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Table 3 | Tyrosine phosphorylation sites identified.
Rv number Protein name Tyrosine phosphopeptides Biological Function References
Rv0020c FhaA GGQGQGRPDEY*YDDR Signal transduction This study
GGYPPETGGYPPQPGY*PRPR This study
HEEGSY*VPSGPPGPPEQR This study
HPDQGDY$PEQIGYPDQGGYPEQR Kusebauch et al., 2014; This study
QDYGGGADY$TR Kusebauch et al., 2014; This study
VPGY$APQGGGYAEPAGR Kusebauch et al., 2014; This study
Rv0421c Rv0421c GLAEGPLIAGGHS*Y*GGR Hypothetical This study
Rv0440 GroEL2 QEIENSDSDY$DREK Protein refolding Kusebauch et al., 2014; This study
Rv0613c RecC IVLAGY*DEELLER Exonuclease V gamma chain This study
Rv1513 Rv1513 HQDAFPPANY*VGAQR Hypothetical This study
Rv2198c MmpS3 ASGNHLPPVAGGGDKLPSDQT*GETDAY*SR Integral Membrane protein This study
AYS*APESEHVTGGPY$VPADLR Kusebauch et al., 2014
AYS*APESEHVT*GGPY*VPADLR This study
Rv3418c GroS Y*GGTEIK Response to stress This study
Rv3628 Ppa HFFVHY*K Phosphate metabolic process This study
#Previously identified pY site.
*Novel pY site identified in this study.
$pY site identified in current and previous studies.
Table 4 | List of phosphorylated ribosomal proteins identified in this study and other bacteria.
Protein name Protein name Phosphopeptides Phospho-residue References
rpsC Streptomyces coelicolor Not known Not known Mikulík et al., 2011
M. tuberculosis NPES*QAQLVAQGVAEQLSNR S This study
AAGGEEAAPDAAAPVEAQSTES* S This study
rpsS M. tuberculosis HVPVFVTES*MVGHK S This study
rplC Streptomyces coelicolor Not known Not known Mikulík et al., 2011
Streptococcus pneumonia Not known Not known Zhang et al., 2000
Halobacterium salinarum Not known Not known Aivaliotis et al., 2009
M. tuberculosis IVVEVCSQCHPFYT*GK T This study
rplX M. tuberculosis S*GGIVTQEAPIHVSNVMVVDSDGKPTR S This study
rpmC Streptococcus agalatiae FQAAAGQLEKT*AR T Burnside et al., 2011
Streptomyces coelicolor RERELGIET*VESA T Manteca et al., 2011
Listeria monocytogenes FQLATGQLENT*AR T Misra et al., 2011
DLSTTEIQDQEK Not known Misra et al., 2011
Lactococcus lactis MKLSETK Not known Soufi et al., 2008
M. tuberculosis ELGLATGPDGKES* S This study
rpmE Klebsiella pneumonia S*TVGHDLNLDVCGK S Lin et al., 2009
Halobacterium salinarum ASSEFDDRFVTVPLRDVTK Not known Aivaliotis et al., 2009
M. tuberculosis T*GGLVMVR T This study
*Novel pY site identified in this study.
from elsewhere (Lakshminarayan, 2009). Furthermore, we iden-
tified a number of STPK substrates that were phosphorylated
in clinical hyper-virulent M. tuberculosis strain (list not shown)
thereby highlighting the complexity of the phosphorylation regu-
latory network in M. tuberculosis. Even though the role of STPKs
in bacterial physiology is not yet fully understood the data pre-
sented here could underpin a targeted approach to improving
our understanding of STPK-mediated signal transduction mech-
anisms in M. tuberculosis.
TYROSINE PHOSPHORYLATION
The M. tuberculosis genome encodes for two putative tyrosine
phosphatases (PtpA and PtpB) but is not predicted to encode
tyrosine kinases (Cole et al., 1998; Bach et al., 2009). Most bac-
terial phosphorylation sites are on serine and threonine; a survey
of 11 bacterial phosphoproteomes revealed that S/T phospho-
rylation accounted for an average of 48 and 40% of phospho-
rylated sites, respectively, while tyrosine phosphorylation events
account for less than 10% of the overall phosphoproteome (Ge
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and Shan, 2011). Tyrosine phosphorylated proteins have been
previously shown to play important regulatory roles through
their involvement in biological functions such as exopolysaccha-
ride production, DNA metabolism, stress responses (Ge et al.,
2011; Whitmore and Lamont, 2012). Recently, Kusebauch et al.
identified tyrosine phosphorylated proteins in M. tuberculosis
and demonstrated that a number of STPKs can phosphorylate
tyrosine in either cis or trans (Kusebauch et al., 2014). This sug-
gests that STPKs have the ability to phosphorylate S/T/Y. In this
study we identified 13 tyrosine phosphorylation sites in 8 pro-
teins (Table 3). An overlap of three proteins (FhaA, MmpS3, and
GroES) and 6 tyrosine phosphorylated sites we similar between
this and the previous study (Kusebauch et al., 2014). Five of
the tyrosine phosphorylated proteins (FhaA, GroEL2, MmpS3,
GroES, and Ppa) identified in this study are essential for in vitro
growth (Sassetti et al., 2003; Griffin et al., 2011) and involved in a
variety of functions.
This study confirmed and expanded work by Kusebauch
et al., where multiple tyrosine phosphopeptides were identified
for FhaA. FhaA is a regulatory protein which has been impli-
cated in cell wall biosynthesis (Fernandez et al., 2006) and has
a strong association with PknA and PknB (Pallen et al., 2002;
Roumestand et al., 2011). We found that the highly S/T/Y phos-
phorylated FHA-domain contained 6 tyrosine phosphopeptides
of which 4 were previously been identified in H37Rv (Kusebauch
et al., 2014). FhaA is a major substrate of PknB and has been
implicated in the formation of a regulatory complex with MviN
required for peptidoglycan biosynthesis (Warner and Mizrahi,
2012). In our dataset, we found that all three of the pro-
teins (PknB, FhaA, and MviN) in the regulator complex were
phosphorylated.
We also confirm the presence of a previously reported Y
phosphopeptide of MmpS3 and identified a second phospho-
peptide. MmpS3 forms part of the mycobacterial membrane
protein small family and is an essential protein for mycobac-
terial growth and cholesterol metabolism (Griffin et al., 2012).
The role of phosphorylation of this protein has yet to be
determined.
The two proteins GroEL2 and GroES have been identified as
potential candidates for antituberculosis treatment (Al-Attiyah
et al., 2006). We confirmed the presence of the Y phosphopep-
tide in GroEL2 identified in H37Rv (Kusebauch et al., 2014).
Recently it has been shown that the antigen GroES is sufficient
to protect BALB/c mice against challenge infection (Lima et al.,
2003) and up-regulated in kanamycin and amikacin resistant iso-
lates (Kumar et al., 2013). Ppa is an inorganic pyrophosphate
and is involved in macromolecule biosynthesis. The M. tuber-
culosis Ppa is highly similar to a well conserved homolog of
Legionella. pneumophila PPase which is induced in macrophages,
although the M. tuberculosis PPa promotor is not respon-
sive to any specific intracellular triggers (Triccas and Gicquel,
2001).
VIRULENCE FACTORS
The identification of virulence factors is crucial in order to
improve our understanding of themechanisms involved in patho-
genesis ofM. tuberculosis. Several of the phosphorylated virulence
factors identified in this study were found to be involved in
basic metabolic pathways such a lipid and fatty acid metabolism,
secretion systems and response and adaptation to environmental
changes. The virulence factor KasB and key enzymes (FadD32,
AccD4, and MmaA3) in the mycolic acids biosynthesis path-
way were phosphorylated in this hyper-virulent M. tuberculosis
strain. The kasB gene is not essential for growth, however, the
deletion mutant, kasB, resulted in an alteration in growth mor-
phology and loss of acid-fast staining (Bhatt et al., 2007). This
suggests that modification of this protein could influence the
synthesis of mycolic acids and thereby the pathogenicity of the
bacilli.
The specialized ESX-1 Type VII secretion system (T7SS),
unique to pathogenic mycobacteria is responsible for the secre-
tion of two culture filtrate proteins EsxA and EsxB (ESAT-6 and
CFP-10). These secretion systems have been shown to be involved
in virulence and are critical for intracellular survival (Bitter and
Kuijl, 2014) due to their ability to secrete proteins that lack clas-
sical signal peptides across the complex cell envelope to host
cells during infection (Houben et al., 2014, p. 5). M. tuberculo-
sis have several different ESX regions (ESX-1 to ESX-5) (Daleke
et al., 2012) with varying gene numbers and size for each of
these secretion machinery. In this study we found 6 T7SS proteins
to be phosphorylated in the hyper-virulent strain. In a previous
study, proteomics of whole cell extracts of this hyper-virulent
M. tuberculosis strain revealed an under-representation of viru-
lence factors such as ESAT-6 and Esx-like proteins (de Souza et al.,
2010). The authors showed the abundance of ESAT-6 gene expres-
sion was reduced in the hyper-virulent M. tuberculosis suggesting
that the low levels of this protein might be as a result of its abil-
ity to export these proteins more efficiently into the extracellular
environment (de Souza et al., 2010).
PROTEIN SYNTHESIS AND INTERACTIONS
The impact of phosphorylation on the functionality of riboso-
mal proteins is not fully understood. Mikulik et al. hypothesized
that phosphorylation of ribosomal proteins induces or stabilizes
conformational changes during proteins synthesis which could
allow modification of subunit association or changes in interac-
tions with proteins and RNAs (Mikulík et al., 2011). According
to the protein phosphorylation database, phosphopeptides of
RpmC have been identified in four different bacteria (Soufi et al.,
2008; Burnside et al., 2011; Manteca et al., 2011; Misra et al.,
2011). The implication of phosphorylation on RpmC has not
been investigated. However, in E.coli, RpmC, RplW and Trigger
factor are located at the exit tunnel in the ribosome, suggest-
ing that phosphorylation may impact on multiple stages of
transcription (Kramer et al., 2002). In our study we identified
phosphopeptides for 7 ribosomal proteins. We also identified
unique phosphopeptides on ribosomal proteins RpsS and RplX
(Table 3).
OVERLAP OF PHOSPHORYLATED PROTEINS WITH OTHER BACTERIA
Twenty-five of phosphorylated proteins identified in our study
were also identified in phosphoproteomics studies of other bac-
teria such as Klebsiella pneumonia (Lin et al., 2009), Helicobacter
pylori (Ge et al., 2011), Steptococcus pneumonia (Sun et al., 2010),
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Bacillus subtillis (Macek et al., 2007), Halobacterium salinarum
(Aivaliotis et al., 2009), etc. (Table 4). In our dataset the distri-
bution of S/T/Y seem to be bias toward pT and is in accordance
with previously described phosphoproteomes of M. tuberculosis
(Prisic et al., 2010; Kusebauch et al., 2014). Manual evaluation
of the genome found an over-representation of Threonine rel-
ative to Serine (52:48%). This compared to other bacteria such
as Acinetobacter baumannii (Soares et al., 2014), Bacillus sub-
tilis (Macek et al., 2007), Escherichia coli (Macek et al., 2008;
Soares et al., 2013) andHalobacterium salinarum (Aivaliotis et al.,
2009), Pseudomonas aeruginosa (Ravichandran et al., 2009), and
Streptomyces coelicolor (Parker et al., 2010) which demonstrate a
bias toward pS.
Forty-five of the phosphorylated proteins identified in our
study were previously described for M. tuberculosis H37Rv (Boitel
et al., 2003; Young et al., 2003; Molle et al., 2004, 2006; Durán
et al., 2005; Kang et al., 2005; Villarino et al., 2005; O’Hare et al.,
2008; Thakur et al., 2008; Prisic et al., 2010; Sajid et al., 2011; Gee
et al., 2012). The reason for not identifying all of the previously
identified phosphorylated proteins in the protein phosphoryla-
tion database could be ascribed to different genetic backgrounds
of the analyzed M. tuberculosis strains, culture conditions, sam-
ple preparation and different MS-based proteomics approaches
used in each of the studies. Our analysis was performed on a
hyper-virulent clinical isolate of M. tuberculosis and a member of
the Beijing genotype which is genetically distinct from the lab-
oratory strain M. tuberculosis H37Rv analyzed by Prisic et al. and
Kusebauch et al. In addition, the Prisic et al. study reported on the
combined phosphoproteome from 6 different conditions (5 dif-
ferent culture conditions and 2 different growth phases) (Prisic
et al., 2010) while Kusebauch et al. reported on the phospho-
proteome of late-logarithmic phase cultures (Kusebauch et al.,
2014), whereas our study analyzed early-logarithmic phase cul-
tures. Even though the overlap between our study of clinical
M. tuberculosis and that of the previously described laboratory
M. tuberculosis H37Rv is low this work substantially extends our
knowledge of the M. tuberculosis phosphoproteome. During log-
arithmic growth phase of bacterial growth the cells are adapting
to the environment of the growth media and biological process
such as RNA synthesis, DNA replication and synthesis of micro-
and macromolecules are up-regulated. It is important to note
that in this study the whole cell lysate proteins were enriched
for phosphopeptides and we detected a number of phospho-
rylated proteins involved in these biological processes such as
fatty acid- and lipid biosynthetic metabolism; RNA modification
and translation; DNA repair, replication and modification. It is
believed that environmental conditions, cell density and growth
phase influence the expression of virulence factors by a pathogen
(McIver et al., 1995). This is consistent other bacterial phospho-
proteomes, thereby emphasizing that S/T/Y phosphorylation is
an important process required for the regulation of numerous
cellular processes.
CONCLUSION
Recent developments in the methodology and mass spectrom-
etry technology for phosphoproteomics have highlighted the
need to explore the involvement of phosphorylation in disease
development and progression. However, the impact of the pro-
tein phosphorylation cascade on the physiology of pathogenic
bacteria such as M. tuberculosis has yet to be fully elucidated.
Improved preparative techniques and more sensitive instrumen-
tation are required to fully appreciate the complexity of protein
modification. This can only be achieved if concomitant methods
are developed to elucidate the impact of phosphorylation on pro-
tein function. Although this qualitative study was done in clinical
hyper-virulent M. tuberculosis, without any follow-up validation
studies it still provides a valuable resource for further investi-
gating and understanding the impact of protein phosphorylation
regulation in M. tuberculosis.
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